Dr. Dima Abdelmannan, is an Associate Professor and Vice Clinical Dean of Dubai Medical College in Dubai, U.A.E. Dr. Dima Abdelmannan is also a Consultant Endocrinologist at the Dubai Diabetes Center at Dubai Health Authority. Dr. AbdelMannan has dual boards from both the UK and the USA. In the United States she completed her internal medicine residency training from the Cleveland Clinic Health System and then completed fellowship training in Endocrinology, Diabetes and Metabolism at Case Western Reserve University, in Cleveland, OH. She continued to do clinical and Research work at the same institution for several years before returning to Dubai, UAE to hold an academic position. Her research work is in the fields of Pituitary and adrenal diseases as well as Diabetes. She has presented her work at national American meetings and published it in peer-reviewed journals. Besides being interested in Clinical Endocrinology and research she has been interested in Medical Education and therefore took this leading role at the medical school in order to help improve the standards of medical education in Dubai and the UAE. Dr. Abdelmannan is a scholar of the Harvard Macy Institute of Health professionals as educators and is actively involved in implementing efficient ways in medical pedagogy including simulation and e-learning.
Dr. Elham Al Amiri is a Pediatric Endocrinologist at Al Qassimi Hospital, Sharjah and an adjunct Associate Professor in Sharjah University, UAE. She had a Master Science degree in Pediatric from Dublin, Ireland. Having finished her clinical ESPE fellowship, she organized the first ESPE Post Fellowship Endocrinology Conference in the Middle East. Dr. Al Amiri is the founder of “Friends for Diabetes” support group.
Professor Melanie Davies is an Honorary Consultant Physician in the University Hospitals of Leicester NHS Trust and, since February 2006, Professor of Diabetes Medicine at the University of Leicester. Much of her research work is around the cause of Type 2 Diabetes, screening and prevention of Type 2 Diabetes Mellitus, and self-management and structured education.
As one of the leading experts in the UK, Professor Davies has been actively involved in the work of Diabetes UK. Professor Davies has been a member of the NICE Type 1 Diabetes Guidelines Group, Type 2 Diabetes Guidelines Group, NICE Quality Standards Group and NICE Prevention of Type 2 Diabetes. She has Global and National Principal Investigator roles for many large international clinical trials in the field of diabetes and has presented her work around the world at international meetings. She is also a senior NIHR Investigator.
Professor Davies is the National Lead for the DESMOND Collaborative in the UK, which has conducted one of the largest global trials on structured education in Type 2 Diabetes Mellitus. She is Co-Director of the South East Midlands Diabetes Research Network (SEN DRN), and has been awarded an NIHR Programme Grant of £2 million for a community diabetes prevention trial, and was a key applicant in the successful regional CLAHRC bid in the East Midlands. She was recently appointed East Midlands Strategic Health Authority Diabetes Clinical Lead for Long Term Conditions.
Internationally, she has worked with the WHO and IDF in Central Asia, and has been an invited speaker at many international congresses. Professor Davies is an expert advisor to NICE, and a member of the Vascular Board.
Dr. Asma Deeb is a Consultant and Chief of Pediatric Endocrinology at Mafraq Hospital, Abu Dhabi. She trained in the UK since 1991. Dr. Deeb obtained an MD degree in Growth Hormone Gene Expression in 2002 from University of Newcastle. She was appointed as a Clinical Lecturer in Pediatric Endocrinology at the University of Cambridge between 2001 and 2005 and obtained a CCST in Paediatric Endocrinology. Dr. Deeb has special interest in disorders of sexual differentiation, use of technology in management of children with diabetes and genetics of diabetes mellitus in which she has published in Peer Review Journals.
Dr. Seán Dinneen graduated from University College Cork Medical School in 1985. After a period of postgraduate training in Ireland he travelled to the USA where he completed training in Internal Medicine and Endocrinology at the Mayo Clinic in Rochester, Minnesota. He was awarded a Mayo Foundation Scholarship and completed a Masters in Clinical Epidemiology at McMaster University, Hamilton, Ontario, Canada before returning to a staff position at the Mayo Clinic in the Division of Endocrinology with a joint appointment to the Division of Health Services Research. In 2000 he was appointed as a Community Diabetologist in Addenbrooke’s Hospital, Cambridge, UK, one of the first such appointments in the NHS. Dr. Dinneen returned to Ireland in 2005 as a Senior Lecturer in Medicine (NUI Galway) and Consultant Endocrinologist (Galway University Hospitals). In December 2013 Dr Dinneen was appointed Head of the School of Medicine in NUI Galway.
His professional interests include developing and evaluating programmes of self-management education for people with diabetes, developing optimal models of community-based diabetes care and understanding the diabetic foot. Over the past 10 years he has secured research funding of over 2,250,000 from the Health Research Board, Enterprise Ireland, Diabetes Ireland (through the Medical Research Charities Group) and the European Foundation for the Study of Diabetes. In addition he was part of successful bids which brought a School of Podiatry and a Clinical Research Facility to NUI Galway. He has acted as PI on 3 multi-centre clinical trials through the CRFG. Dr Dinneen has served as National Specialty Director for Endocrinology and Diabetes Mellitus in the Royal College of Physicians of Ireland since 2009; in this role he oversees all aspects of postgraduate training of Endocrinology Trainees in the Republic of Ireland. In 2014 Dr Dinneen was honored with the Nordisk Medal from the Irish Endocrine Society; this medal is awarded to a member of the Society in recognition of a body of research work carried out on the island of Ireland. Dr Dinneen delivered the Annual Nordisk Lecture entitled “Exploring the Chronic Care Model: a Diabetes Journey”.
Recent professional achievements include delivering to completion a large multi-centre study evaluating 2 different methods of follow-up of patients with type 1 diabetes following structured education (the Irish DAFNE Study), delivering to completion a cohort study assessing risk factors for foot ulceration in a community cohort (The West of Ireland Diabetes Foot Study) and being appointed Chair of the EASD’s (Extra-European) Postgraduate Education Committee (April 2013). Recent personal achievements include climbing Mount Kilimanjaro (2007), learning to swim (2009), walking the last 110 km of the Camino de Santiago (2010) and trekking the Haute Route from Chamonix to Zermatt (2014).
James W. Findling, MD, FACP is Professor of Medicine and Director of the Endocrine Center and Clinics at the Medical College of Wisconsin. He is a graduate of the University of Notre Dame and Northwestern University Medical School. He completed his internal medicine training at the Medical College of Wisconsin and his post-doctoral fellowship in Endocrinology and Metabolism at the University of California-San Francisco. He started his endocrinology practice at St. Luke's Medical Center in Milwaukee in 1982 and he started the Endocrine-Diabetes Center at St. Luke's in 1987.
Dr. Findling joined the full-time faculty of the Medical College of Wisconsin in 2008. He has over 100 publications and book chapters and is considered an international expert on clinical disorders of pituitary and adrenal function. He has served as visiting professor at many institutions including the Mayo Clinic, Massachusetts General Hospital, Johns Hopkins, University of Iowa, University of Kansas, University of Texas-Southwestern, University of Colorado, University of Nebraska, University of Pittsburgh, and the Cleveland Clinic.
Dr El-Hajj Fuleihan is Professor of Medicine, founding Director of the Calcium Metabolism and Osteoporosis Program, and of the WHO Collaborating Center for Metabolic Bone Disorders, Founding and Program Director, Scholars in HeAlth Research Program, at the American University of Beirut, Beirut, Lebanon. Dr El-Hajj Fuleihan obtained her MD degree from the American University of Beirut and completed her residency and fellowship at the New England Deaconess and Brigham and Women’s Hospitals, Harvard Medical School, Boston. She received a master in Public Health from the Harvard School of Public Health and directed the Calcium Metabolism Research Unit at the Brigham and Women’s Hospital, Harvard Medical School for several years prior to moving back to her Alma Mater.
Dr. El-Hajj Fuleihan’s major research interests revolve around, osteoporosis, hypovitaminosis D, metabolic bone disorders, calcium-sensing, and women’s health issues. Her vitamin D program spans epidemiology to cohort as well as randomized controlled trials across the lifespan. . Her research laboratory has enrolled several hundred study participants over the years, in physiologic, genetic, cross-sectional or longitudinal studies. Dr El-Hajj Fuleihan has mentored over 40 postgraduate trainees, including many Medical Doctorate graduates, junior faculty, and several Master Thesis Students and a PhD student. She has published on her topics of interest in over 130 publications, including peer-reviewed first tier original investigations, several invited Editorials and commentaries in the New England of Medicine and Journal of Clinical Endocrinology and Metabolism, Nature Reviews Endocrinology http://staff.aub.edu.lb/~webcmop/publications.html.
Dr El-Hajj Fuleihan serves on the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF), the Board of Directors of the International Bone and Mineral Society (IBMS), and is a member of the Nutrition Committee, WHO Geneva. She serves on the Annual Meetings Steering Committees of the IBMS, and is a full faculty member for of the International Society of Clinical Densitometry (ISCD) certification courses. She serves on the editorial boards of the Journal of Bone and Mineral Research, Journal of Clinical Densitometry, and Metabolism Clinical and Experimental. She co-chaired the Task Force for the 2010 IOF-ISCD FRAX International Initiative; led the 2011 IOF Middle East-Africa Osteoporosis Audit; and is co-chairing the 2014 ASBMR Task Force on Managing Osteoporosis Patients after Long Term Bisphosphonate Treatment .
Prof. Hossein Gharib received a B.S. degree from the Ohio State University in 1962. He went on to receive a medical degree from the University of Michigan Medical School in 1966, and took his internship at Philadelphia General Hospital from 1966 to 1967. He completed an internal medicine residency (1967–1969) and fellowship in endocrinology and metabolism (1969–1971) at the Mayo Clinic in Rochester, Minnesota. After a visiting fellowship in reproductive endocrinology at the Columbia University College of Physicians & Surgeons in New York City, he joined the Mayo Clinic faculty in Rochester in 1972.
In 1974, he went back briefly to Iran where he served on the faculties of the University of Tehran and the National University Medical Schools. During his tenure in Iran, he was initially a consultant at the Queen Heart Hospital before he was appointed the Medical Director of the Reza Pahlavi Medical Center (1975–1977). Dr. Gharib later became the Associate Dean of the College of Health Sciences (1977) and served as the director of the Department of Internal Medicine at Saadat-Abad Medical Center, National University (1977–1979). In June 1979, he returned to the Mayo Clinic in Rochester where he is now Professor of Medicine at the Mayo Clinic College of Medicine, and a consultant in the Division of Endocrinology, Metabolism, and Nutrition. He also teaches medical residents and endocrine fellows, and conducts clinical research.
Dr. Hossein Gharib has become an internationally-known authority on thyroid disorders.
John graduated from Dundee University and trained in paediatric diabetes in Sheffield, Dundee and Newcastle upon Tyne. He provides a diabetes service for approximately 235 children with diabetes living in Cardiff and leads a research programme investigating delivery of clinical care to children with diabetes. He has completed research studies evaluating communi cation skills training for healthcare professionals (Robling M et al. The DEPICTED Study. BMJ. 2012 Apr 26;344:e2359. doi: 10.1136/bmj.e2359), examining transition to adult services (Allen D et al. The TCADS Study. J Health Serv Res Policy. 2012 Jul;17(3):140-8. Epub 2012 Jul 5.), evaluating how children make choices about healthcare (Noyes JP et al. The EPIC Study. Southampton (UK): NIHR Journals Library; 2014 Mar) and evaluating models of care for children at diagnosis (Townson JK et al. The DECIDE Study. BMC Pediatr. 2011 Jan 19;11:7. doi: 10.1186/1471-2431-11-7). He currently contributes to a randomised controlled trial of multiple daily injections with pumps (The SCIPI Study). John is co-author of Practical Endocrinology and Diabetes in Children, now in its third edition.
George Grunberger, MD, FACP, FACE is the Chairman of Grunberger Diabetes Institute (GDI) in Bloomfield Hills, Michigan. Dr. Grunberger is also Clinical Professor of Internal Medicine and of Molecular Medicine & Genetics at Wayne State University School of Medicine (Detroit, MI), Professor of Internal Medicine at Oakland University William Beaumont School of Medicine (Rochester, MI) as well as Visiting Professor in the First Faculty of Medicine at Charles University in Prague (Czech Republic).
Before forming GDI in 2002, Dr. Grunberger established and directed for 16 years the Diabetes Program at the Detroit Medical Center and Wayne State University’s Comprehensive Diabetes Center. Between 1986 and 2002. Dr. Grunberger was tenured Full Professor of Internal Medicine and of Molecular Medicine and Genetics. Dr. Grunberger came to Detroit from the Diabetes Branch of NIDDK/NIH in Bethesda, MD where he trained in endocrinology/metabolism and then worked there as a basic and clinical researcher for six years. Dr. Grunberger received his internal medicine training at the University Hospitals of Cleveland at Case Western Reserve University, his medical (M.D.) training at the New York University School of Medicine and his bachelor’s degree (in biochemistry) at Columbia College of Columbia University, also in New York City.
Dr. Grunberger’s clinical and basic research endeavors have been well recognized. He has published well over hundred original peer-reviewed manuscripts, in addition to review articles, abstracts, book chapters, and letters to journals. His research interests have spanned the spectrum of subjects related to diabetes and its complications, from basic studies on molecular underpinning of insulin action and insulin resistance to clinical research studies on many aspects of diabetes and its management. He has trained a generation of young basic and clinical research investigators. He is currently a co-editor of two international diabetes journals.
Dr. Grunberger has been active in several professional societies (American Diabetes Association, American Association of Clinical Endocrinologists, The Endocrine Society, European Associations for Study of Diabetes, etc.) where he has held elected positions of leadership. He now serves as President of AACE.
Dr. Andrew Hall graduated from Cambridge University in 1986 and University College London in 1989. His training included acute general medicine, chest medicine and cardiology in Ipswich, neurology & neurosurgery in Cambridge and anaesthesia & intensive care in Leicester and Nottingham. He was appointed Consultant in Anaesthesia and Intensive Care Medicine at Leicester Royal Infirmary in 1999.
Dr Hall subsequently developed an interest in sleep medicine. In 2004, he joined the team at Leicester General Hospital, one of the first sleep laboratories in the UK. Since 2007 he has been Head of Adult Sleep Medicine at the University Hospitals of Leicester NHS Trust and leads an ever growing department of 4 physicians and 6 technologists.
His research interests and recent publications relate to obstructive sleep apnoea (OSA) and metabolic medicine, the peri-operative management of patients with OSA and aspects of other sleep disorders such as insomnia and narcolepsy.
Amir H. Hamrahian, MD, is Chief of Endocrinology in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi. He specializes in Endocrinology, Diabetes, and Metabolism.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Hamrahian served as the Director of Clinical Research at the Endocrinology and Metabolism Institute, and the Director of the Endocrinology Fellowship Program at US-based Cleveland Clinic.
He specializes in Endocrinology, Diabetes, and Metabolism and has special interests in pituitary and adrenal disorders. Dr. Hamrahian has published more than 65 peer reviewed articles, along with more than 70 abstracts and book chapters. He has given presentations on pituitary and adrenal disorders at national meetings of the Endocrine Society and the American Association of Clinical Endocrinologists (AACE) annual meetings. He served as co-author on AACE adrenal incidentaloma, cushing and acromegaly guidelines, and has participated in the international consensus conferences on diagnosis and management of acromegaly. He has served as the principal investigator for a number of pituitary-related clinical research studies. He initiated and co-directed an annual Pituitary Day Conference in Cleveland from 2005 to 2014.
Dr. Hamrahian received his medical degree from Hacettepe University in Ankara, Turkey. He completed his Internal Medicine residency at the University of North Dakota in Fargo, North Dakota and his fellowship in Endocrinology at Case Western Reserve University in Cleveland, Ohio.
Dr. Frances J. Hayes is Clinical Director of the Endocrine Division at the Massachusetts General Hospital, Associate Chief for Clinical Affairs and Education in the Reproductive Endocrine Unit and an Associate Professor of Medicine at Harvard Medical School. She is a graduate of University College Dublin medical school in Dublin, Ireland and completed her training in internal medicine and endocrinology at St. Vincent’s University Hospital in Dublin before moving to Boston in 1996.
Dr. Hayes’ area of expertise is human reproductive physiology, a topic on which she has published widely. Her research interests include the neuroendocrine regulation of fertility in men, androgen replacement therapy in men and the relationship between gonadal steroids and insulin resistance. She is a co-author on the Endocrine Society clinical practice guidelines on the diagnosis and treatment of androgen replacement in men.
Her clinical practice covers the spectrum of reproductive endocrinology including polycystic ovary syndrome, infertility, and male and female hormone replacement therapy for hypogonadism. She has expertise in ovulation induction with clomiphene, gonadotropins and pulsatile GnRH for women with idiopathic or anovulatory infertility and use of gonadotropins to stimulate spermatogenesis in men with hypogonadotropic hypogonadism.
Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust, UK. He received his clinical diabetes training at Queen’s Medical Centre, Nottingham and his research training at the University of Nottingham and Washington University, St Louis, USA. From 2000-2005 he was Editor of Diabetic Medicine. He is currently a member of Diabetes UK Science and Research Advisory Group, a member of the UK NIHR Health Technology Assessment Panel and the UK Juvenile Diabetes Research Foundation, UK Scientific Advisory Committee. Between 2005 - 2014 he chaired the Clinical Studies Advisory Group of the UK Diabetes Research Network and is currently the National Speciality Lead in Diabetes to the NIHR Clinical Research Network.
His current research interests include the pathophysiological responses to hypoglycaemia and hypoglycaemia unawareness, the potential contribution and mechanisms of hypoglycaemia to cardiovascular mortality, the use of insulin analogues and other technologies to reduce hypoglycaemia. He chaired the glucose control group of the ADVANCE trial and is a steering committee member of the EXAMINE trial. He also conducts research programmes concerned with developing interventions (including the DAFNE course) to encourage more effective diabetes self-management. He has authored over 200 original research articles and reviews.
Prof Ismail qualified from the University of Oxford and is Professor of Psychiatry and Medicine at the Institute of Psychiatry, King’s College London and Consultant Liaison Psychiatrist at King’s College Hospital NHS Foundation Trust. Her research interests are in understanding the epidemiology and underlying mechanisms of the depression-diabetes link and related disorders. Her research interest also resides in developing and evaluating complex interventions to improve diabetes control and depression.
Prof. Ismail leads the Diabetes and Mental Health Research Group and the Diabetes and Psychiatry clinical service at King’s Health Partners. Her research has been translated into innovative clinical services such as the 3 Dimensions of Care for Diabetes service (3DFD) which won 3 Quality in Care Awards 2011. She has developed training modules to improve skills in psychological care for health professionals working with people with diabetes.
Dr. Al Jubeh is the acting Chairman of Pediatrics at Sheikh Khalifa Medical City. He is a consultant pediatric endocrinologist at SKMC since 2006. He graduated from the medical school at the University of Jordan then completed his training in pediatrics and pediatric endocrinology at the University of Texas Medical Branch in Galveston, Texas, USA. He is American Board certified in pediatrics and pediatric endocrinology. He worked as a consultant pediatric endocrinologist at Saudi Aramco Dhahran medical center until 2006. He has several publications in peer reviewed journals and he is core faculty in the pediatric residency program at SKMC and adjunct staff in the pediatric department, Cleveland Clinic, USA.
Dr. Kaplan is the Chief of Pediatric Endocrinology at Tawam Hospital, and Associate Professor at the Faculty of Medicine, UAEU, he previously held the positions of Acting Chief Medical Officer, Tawam Hospital, and Assistant Professor Pediatric Endocrinology and Metabolism at The Baylor College of Medicine, Texas Children’s Hospital, Houston, Texas. He is certified by The American Board of Pediatrics and Sub-board of Pediatric Endocrinology.
Dr. Kaplan received his MD from the Damascus University, School of Medicine. He completed his internship and residency at the University of Illinois at Chicago, and Hurley Medical Center, Flint, Michigan, and sub-specialty training in Pediatric Endocrinology at Baylor College of Medicine Houston, Texas. Additionally, he obtained his Academy Fellowship Certificate in 2008.
Dr. Kaplan has noteworthy Administrative Experience. He is the Acting Chief Quality Officer and the Chairman of Privileging and Credentialing Committee at Tawam Hospital. He chaired the Department of Pediatrics, Tawam Hospital, Johns Hopkins International from 2005-2010, during the same time, he was quite involved in the preparation for the initial JCIA accreditation and subsequent re-accreditation of Tawam Hospital, Medical Staff Privileging and Credentialing, and a new hospital-wide, objective-based physicians performance evaluation system.Dr. Kaplan also was the Pediatric Chief Resident during 2003-2004, at Michigan State University and served as Medical Director at Port Arthur Community Health Center, Inc. 1995-1998.
Dr. Kaplan is sub-specializes in pediatric diabetes and endocrinology, and he attends a regular clinic at Tawam Hospital. He is a member of Lawson Wilkins Pediatric Endocrine Society, The Endocrine Society, The Emirates Diabetes Society, and UAE Endocrine Club.
Dr. Kaplan has received several awards for outstanding achievement, such as Government Scholarship after finishing medical school, Certificate of Excellence from Port Arthur Community Health center in 2000, National Diabetes Guidelines Appreciation Award by UAE Ministry of Health in 2009, and listed among America’s Top Pediatricians in 2010.
Dr. Abdul Salam Al-Kassab is the President of Endocrine and Diabetes Consultants in Rochester Hills, Michigan, USA. He graduated from the University of Baghdad Medical School. He pursued post graduate education in the UK and Ireland where he obtained a PhD degree as well as a Membership of the Royal College of Physicians of Ireland.
He is an Associate Clinical Professor in Medicine and Endocrinology at Wayne State University Medical School and Oakland Universities. He is Board Certified in Internal Medicine, as well Diabetes and Endocrinology. He is the author of multiple articles in peer reviewed journals in the fields of Diabetes and Endocrinology. He is also involved in Clinical trials in the field of Diabetes as well as growth hormone therapy in adults.
Dr. Aly Bernard Khalil originally qualified from the University of Marseilles, France in 1976 and is certified by the American Board of Internal Medicine since 1988 and the American Board of Endocrinology and Metabolism since 1995 (recertified 2005). He joined the American Hospital in Beirut as a Fellow in 1978 and then moved to Canada in 1980, following which he proceeded to his residency program at the Universities of Toronto and Queens till 1985. From there, he joined the University of Calgary, Alberta till 1989 as a Research Scholar for the Alberta Heritage Foundation. He then was appointed to his clinical position at Queen’s Hospital, Toronto as a Consultant in Internal Medicine and Endocrinology and Chair of Endocrinology till 2000. In 1999, he assumed the role of President of the Toronto Diabetes Association till the time of his move to the Emirates in February 2002 where he joined SKMC as a Senior Consultant in Endocrinology and Critical Care. In 2013, he moved to his current post. Dr. Khalil’s special interest interests are thyroid autoimmunity, thyroid cancer and metabolic disorders.
Márta Korbonits graduated in Medicine in Budapest and undertook her early clinical training at the Internal Medicine Department of the Postgraduate Medical School, Budapest. In 1991, she joined the Department of Endocrinology at St. Bartholomew’s Hospital in 1991 under the mentorship of Professors Ashley Grossman and Michael Besser. Her MD and PhD studies contributed to fuller understanding of the effects of growth hormone secretagogues on hypothalamus hormone release, and the nature and causes of pituitary tumorigenesis. In 2000, she was awarded an MRC Clinician Scientist Fellowship, and commenced studies that produced novel insights into ghrelin physiology and genetics, plus the hormonal regulation of the metabolic enzyme AMPK. In 2008, she was awarded a Personal Chair as Professor of Endocrinology and Metabolism. Professor Korbonits continues to integrate her various human studies alongside laboratory-based research projects and has pioneered several projects in translational medicine, for example on the effect of metformin on glucocorticoid-induced metabolic complications. A major research focus involves the clinical and scientific aspects of familial isolated pituitary adenomas. In 2009-2012, she served as the Conference Program Secretary for the Society for Endocrinology. In 2012, she was appointed, alongside Professor Leo Dunkel, as the Centre Lead for Endocrinology. Professor Korbonits continues to enjoy supervising visiting fellows, PhD, MD and BMedSci students, and serving on the Editorial Boards of the Journals of Clinical Endocrinology and Metabolism, Journal and Neuroendocrinology, and as current or previous board member of various learned Societies, such as the Society for Endocrinology, Pituitary Society or European Neuroendocrine Society. She is an elected member of the Association of Physicians of Great Britain and Ireland.
Rayaz Malik is a Professor of Medicine at Weill Cornell Medical College in Qatar. He obtained his BSc., MSc. and MB ChB from the University of Aberdeen and his PhD from the University of Manchester.
He undertakes translational (T1 to T3) research on neuropathy and cardiomyopathy. He is an expert in the pathogenesis, assessment and treatment of diabetic neuropathy and has been a co-editor for 3 books, co-authored over 30 book chapters and published (~150 peer reviewed papers) and presented (~500 national and international presentations) extensively. His research is funded by the NIH, JDRF, DUK, BHF and EU and his funding totals ~$8M. He is currently supervising 6 PhD’s and has supervised to completion 2 BSc, 3 MRes, 8 PhD and 5 MD students.
He was the Chairman of Neurodiab, the international study group of the EASD for Diabetic Neuropathy (2009-2012). He won the young clinical investigator prize for clinical science for Neurodiab in 1999, North West of England Medical Society Prize in 2000; North East Medical Society Prize 2012. He has been an invited lecturer for the American Diabetes Association 2003, 2007 and 2010, 2012, 2013; European Association for the Study of Diabetes 2004, 2007, 2008, 2010, 2012 and 2013 and World Diabetes Congress 2009, 2011, 2013.
He is an associate editor for Diabetic Medicine (2006 to present); BMC Neurology (2009-present); Advances in Therapy (2009-present) and is on the editorial board for Journal of Diabetes and Its Complications (2012-present) and Journal of Diabetes Investigation (2012-present). He is a grant application reviewer for Diabetes UK, MRC and Welcome Trust, Canadian Diabetes Association, Austrian Diabetes Association and Dutch Diabetes Association. He is on the Juvenile Diabetes Research Foundation Complications and Clinical Investigation Research Committee (2005-2014) and JDRF innovative grant panel 2013-2016. He has undertaken regular reviews for NIDDK and NINDS (2007-present). He served as a reviewer on the MRC DPFS/DCS review panel 2013-2014. He is a regular reviewer for Neurology, Diabetes, Diabetes Care, Diabetologia, and the Lancet.
Roberto Negro, MD, FACE, is Senior Assistant Physician at Endocrine Unit of "V. Fazzi" Hospital in Lecce (Italy) since 2005. Professor of Endocrinology at University of Parma, Italy (2007-2009). Reviewing Editor of Journal of Endocrinological Investigations (2009-2012). Fellow American College of Endocrinology (2011). Reviewing Editor of Journal of Clinical Endocrinology & Metabolism (since 2012). He is author and co-author of more than 40 published papers, having Thyroid and Pregnancy as main field of interest. He has been part of the panel of experts appointed by the American Thyroid Association for the compilation of the Guidelines for the "Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum", and by the European Thyroid Association for the compilation of the "Guidelines for Subclinical Hypothyroidism in Pregnancy and Childhood". Dr. Negro got the following awards and honors: In 2007, the Endocrine Society and Pfizer, Inc. International Award for Excellence in Published Clinical Research in the Journal of Clinical Endocrinology & Metabolism. In 2008, the Endocrine Society and Pfizer, Inc. International Award for Excellence in Published Clinical Research in The Journal of Clinical Endocrinology & Metabolism.
Dr. Al Ozairi has completed her intercalated BMSc (hons) in molecular pathology at Dundee University, United Kingdom (UK) and graduated from Aberdeen University, UK, for her medical undergraduate studies. Dr. Al-Ozairi then joined Newcastle University, UK, for her specialist training in Diabetes and Endocrinology. During her postgraduate studies in the UK, Dr. Al-Ozairi was awarded the Fulbright Fellowship to Joslin Diabetes Center, affiliated with Harvard Medical School, Boston, United States of America.
Dr. Al Ozairi‘s research interest includes diabetes education, metabolic surgery and obesity. Dr. Al Ozairi has been accredited by the Royal College of Physicians, UK, as a Medical Educator, and is an Associate Practitioner at the United Kingdom Higher Education National Academy having completed a teaching fellowship. Dr. Al-Ozairi is the Co- Founder of sokary.org, and won the Arab Regional Award of the World Summit for eHealth Technology. Dr. Al-Ozairi has completed her fellowship in obesity and holds the American Board for Physician Nutrition Specialist. Dr. Al-Ozairi has completed her Rabkin Fellowship in Medical Education at Harvard Medical School. In 2012, Dr. Al-Ozairi has been invited to join the bariatric team at Toronto to help in the development of diabetes and nutritional protocol. Dr. Al-Ozairi is a reviewer for Diabetic Medicine, Obesity Surgery, and Practical International Diabetes. She has 3 chapters in international books and an author in Medscape, Bariatric Times and Endodiabology.
After graduating in 1963 with an MD with distinction from the American University of Beirut, Dr. Salti obtained his Internal Medicine residency training at AUB and then did a fellowship training in Endocrinology and Metabolism at the University of Toronto. He also obtained a PhD in Medical Sciences from the same University.
In 1970 Dr. Ibrahim Salti joined the Division of Endocrinology at AUB and continued till the present. He is currently Professor of Medicine since 1981 and Head of the Division since 1993. Between 1987 until 1993, he served as Deputy President of the University.
He is also a member and fellow of many scientific and professional societies, and a founder of several Lebanese and Arab societies. He has also received several awards and honors. From 1987 till 1993, Prof. Salti served as the Deputy President of the American University of Beirut. At a time when the country was divided, Prof. Salti, the leader, succeeded in reforming the AUB and unifying it after another branch was opened in East Beirut since 1984.
Has over 105 publications and over 440 invited presentations.
Assistant Professor of Clinical Pediatrics, Pediatric Endocrinology and Diabetes, American University of Beirut Medical Center, Beirut, Lebanon. She received her MD form the American University of Beirut in 2001, completed residency training in Pediatrics at Upstate Medical University, Syracuse, NY, USA in 2005 and fellowship training in Pediatric Endocrinology at Children’s Hospital of Pittsburgh of UPMC, PA, USA in 2008. She joined the faculty at Children’s Hospital of Pittsburgh of UPMC from 2008-2010 as a clinical instructor before moving back to AUBMC. She is American Board certified in Pediatrics and in Pediatric Endocrinology. She has special interest in childhood diabetes, insulin resistance and PCOS and has several publications in peer reviewed journals in these fields. She participated as an invited speaker in several international and regional meetings including ENDO society, ESPE and ASPED. She is an active board member of ASPED, and a member of ENDO society, ESPE and ISPAD.
Margaret E Wierman, MD is Professor in Medicine, Physiology and Biophysics at the University of Colorado School of Medicine and Chief of Endocrinology at the Denver VA. She is currently Vice-President (Clinical Scientist) at The Endocrine Society and past President of Women in Endocrinology. She has served on many Endocrine Society committees including chairing the Annual Meeting Steering Committee and the Meetings and Educational Programs Committee, Councillor-at-Large and member of Finance, Nominating and Awards Committees. Maggie chairs the Endocrine Society Task Force on the role of Androgens in Women. She has also served on and chaired multiple NIH Study Sections including the Population Research Subcommittee, the Specialized Programs in Reproduction and the Integrative Clinical Endocrinology and Reproductive Section and served on the Endocrine and Metabolic Drugs panel for the FDA. She received the 2009 Sydney H. Ingbar Distinguished Service Award, given in recognition of distinguished service in the field of Endocrinology.
Current research includes clinical research on the role of neuroendocrine dysfunction after traumatic brain injury and basic research on GnRH neuron and gonadotrope development and function. Clinically she is interested broadly in hormonal disorders of women and men.
John Wilding leads Clinical Research into Obesity, Diabetes and Endocrinology at the University of Liverpool, UK. He trained in medicine in Southampton and at the Hammersmith Hospital, London where he also undertook three years laboratory-based research into the neurobiology of obesity and diabetes. He has worked at University Hospital Aintree, Liverpool since 1996 and as Professor of Medicine since 2005. He has published over two hundred papers, chapters and review articles related to his clinical and laboratory research interests in type 2 diabetes and obesity. His clinical research focuses on the pathophysiology of obesity and diabetes and evaluation of new treatments. He is Chair of the UK National Clinical Research Network Metabolic and Endocrine Speciality Group. He leads specialist services for severe obesity at University Hospital Aintree – designated as a Centre for Obesity Management by the European Association for the Study of Obesity.
Dr. Ali S. Alzahrani is a Professor of Medicine and Endocrinology at Al Faisal University in Riyadh. Dr. Ali Zahrani obtained his Medical Degree from King Saud University in 1990. This was followed by Residency in Internal Medicine at KFSH & RC during the period 1991-1995 and Clinical and Research Fellowship at the John Hopkins School of Medicine in Baltimore, USA during the years 1995-1998. He has been a Consultant Endocrinologist at KFSH & RC since 1998. During the period 2010 to 2011, Dr. Alzahrani was a faculty member and visiting Scientist at the Division of Endocrinology and Metabolism in John Hopkins University, School of Medicine, Baltimore, United States of America. Since his return late in 2011, he has been become a Scientist and Head of the Molecular Endocrinology Division in the Department of Molecular Oncology, Research Center in addition to his Consultant Endocrinology position. Most recently, he has been appointed as a Deputy Executive Director, Research Center at KFSH & RC, Jeddah.
Dr. Alzahrani is proactive in several editorial boards of famously known medical publications. He was the Editor-in Chief of the Annals of Saudi Medicine and an Editorial Board Member of the British Journal of Diabetes and Vascular Medicine. He is an Editorial Board member of the prestigious official journal of the American Thyroid Association, THYROID. Dr. Alzahrani has more than 70 peer-reviewed articles, more than ninty regional and international presentations and has conducted more than ninety lectures nationally and internationally as an invited speaker. Dr. Al Zahrani’s academic interests are clinical and molecular research in the areas of thyroid cancer and endocrine genetics.